版本:
中国

BRIEF-Lundbeck: FDA approves Carnexiv injection

Oct 10 H Lundbeck A/S :

* U.S. FDA approves Carnexiv (Carbamazepine) injection as intravenous replacement therapy for oral carbamazepine formulations

* Plans to make Carnexiv commercially available in the U.S. in early 2017. Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐